Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M111587200 on December 26, 2001

J. Biol. Chem., Vol. 277, Issue 10, 8209-8216, March 8, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/10/8209    most recent
M111587200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kalthoff, C.
Right arrow Articles by Ungewickell, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalthoff, C.
Right arrow Articles by Ungewickell, E. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Unusual Structural Organization of the Endocytic Proteins AP180 and Epsin 1*

Christoph KalthoffDagger , Jürgen Alves§, Claus Urbanke§, Ruth KnorrDagger , and Ernst J. UngewickellDagger

From the Dagger  Department of Cell Biology, Center of Anatomy, and the § Department of Biophysical Chemistry, Center of Biochemistry, Hannover Medical School, D-30125 Hannover, Germany

Received for publication, December 5, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Epsin and AP180/CALM are important endocytic accessory proteins that are believed to be involved in the formation of clathrin coats. Both proteins associate with phosphorylated membrane inositol lipids through their epsin N-terminal homology domains and with other components of the endocytic machinery through short peptide motifs in their carboxyl-terminal segments. Using hydrodynamic and spectroscopic methods, we demonstrate that the parts of epsin 1 and AP180 that are involved in protein-protein interactions behave as poorly structured flexible polypeptide chains with little or no conventional secondary structure. The predominant cytosolic forms of both proteins are monomers. Furthermore, we show that recombinant epsin 1, like AP180, drives in vitro assembly of clathrin cages. We conclude that the epsin N-terminal homology domain-containing proteins AP180/CALM and epsin 1 have a very similar molecular architecture that is designed for the rapid and efficient recruitment of the principal coat components clathrin and AP-2 at the sites of coated pit assembly.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Clathrin-coated vesicles are involved in a number of membrane transport processes, including receptor-mediated endocytosis, recycling of synaptic vesicles, and sorting of lysosomal enzymes (1). Despite our detailed knowledge of the structural components of the coat and the identity of many endocytic accessory proteins, the molecular events leading to coat formation on the plasma membrane remain elusive. Among the factors considered to be important for coat formation are the neuronal proteins AP180, its ubiquitously expressed homolog CALM (clathrin assembly lymphoid myeloid leukemia protein), and epsin 1 (2, 3). All three proteins have a globular epsin N-terminal homology (ENTH)1 domain in common that is constructed from 8 to 10 alpha -helical rods (4-6). This domain mediates binding to the rare membrane lipid phosphatidylinositol 4,5-bisphosphate (PI-4,5-P2), which is generally regarded as a major recruiter of components for the endocytic machinery to the plasma membrane (7, 8). AP180 and epsin 1 interact directly with clathrin and the alpha - and beta -appendage domains of the AP-2 adaptor complex (3, 9-14). AP180 binding to clathrin promotes assembly of clathrin triskelia into a population of small cages with a narrow size distribution (15, 16). In neuronal tissue of Drosophila, a knockout of the AP180 ortholog LAP reduces the number of clathrin-coated vesicles; moreover, their size range is much wider than in wild-type flies (17). These studies have led to the suggestion that AP180 and its orthologs might be involved in the control of vesicle size and thus support the notion of playing an important role in vesicle formation. More recently, the potential of AP180 to recruit clathrin to lipid surfaces and to assemble it there was demonstrated with PI-4,5-P2-containing liposomes and lipid monolayers (7). When a combination of AP-2 and AP180 was added to the monolayer, the clathrin lattices became deeply invaginated (7). Whereas the ENTH domains of AP180 and epsin 1 appear to be predominantly important for membrane binding, their carboxyl-terminal segments are designed for protein-protein interactions. Eight tandemly arranged DPW motifs present in epsin 1 mediate its high affinity interaction with the alpha -appendage domain of AP-2 (9, 12). The association of epsin 1 with the clathrin terminal domain occurs through two clathrin box motifs in the central and carboxyl-terminal parts of the protein (13, 14). The second clathrin box motif is followed by three NPF repeats, which are known to interact with Eps15 homology domains (18). AP180 contains two DPF motifs, which were shown for other endocytic accessory proteins to mediate their interaction with AP-2 (3, 9, 10, 13, 14). In addition, there are three FXDXF motifs present in AP180 that were recently implicated in alpha -appendage binding (19). The central and carboxyl-terminal segments of AP180 lack typical clathrin box motifs; but instead, five DLL repeats were recently implicated in its clathrin assembly function (11). These findings raise the questions why such multiple tandemly arranged binding motifs are needed and how endocytic proteins utilize them. Are they structurally arranged in a way that they are presented to only one interaction partner at a time, or could they possibly interact with more than one target domain simultaneously? Earlier biophysical studies on AP180 from bovine brain coated vesicles suggested an unusually large Stokes radius (15). Analysis of its circular dichroism spectrum indicated 30% alpha -helix, 14% beta -turn, and 27% beta -sheet (20). So far, little is known about the structure of the carboxyl-terminal parts beyond the ENTH domains. Therefore, we have subjected epsin 1 and AP180 as well as recombinant fragments of them to a detailed biophysical analysis using gel filtration, analytical ultracentrifugation, and CD spectroscopy. We conclude that the parts of both proteins that follow their respective ENTH domains are flexible extended polypeptide chains with no relationship to any known conventional secondary structure. Furthermore, we show that epsin 1, like AP180, drives in vitro assembly of clathrin cages and thus might have more functional similarities to other ENTH domain-containing proteins such as AP180 and CALM than previously assumed.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Reagents-- Restriction enzymes and other reagents for molecular biology were obtained from MBI Fermentas (St. Leon-Roth, Germany) and Roche Molecular Biochemicals (Mannheim, Germany). Calibration standards for gel permeation chromatography and sucrose density gradient centrifugation (MW-GF-1000 kit) were from Sigma (Deisenhofen, Germany), and lactate dehydrogenase and catalase were from Roche Molecular Biochemicals. The epsin 1 peptide NH2-CEERIRRGDDLRLQMA-COOH was used for custom immunization in rabbits by Biosciences (Göttingen, Germany). Monoclonal antibody AP180.1 (15) was used to detect AP180. Secondary horseradish peroxidase-conjugated goat anti-rabbit IgG and goat anti-mouse IgG for immunoblots were purchased from ICN/Cappel (Costa Mesa, CA). The blots were developed with ECL reagent (Amersham Biosciences, Inc., Freiburg, Germany).

Expression of Recombinant Proteins-- Epsin 1 cDNA in pBluescript was a gift from Hong Chen and Pietro De Camilli (Yale University). The gene for the full-length protein was obtained by cleavage with SalI and ligation into the SalI site of the pET32c expression vector (Novagen, Madison, WI). Epsin 1 was expressed in Escherichia coli BL21(DE3) pLysS (Novagen) with a fusion tag containing thioredoxin and a His6 cluster. The epsin 1-(144-575) fragment was generated by digestion of the epsin 1 cDNA with PauI and SalI. The 5'-end overhang of the insert was filled in using Klenow polymerase and ligated between the SmaI and SalI sites of the pQE32 vector (QIAGEN Inc., Hilden, Germany). The His6-tagged fusion proteins were expressed in E. coli DH5alpha . The plasmid coding for His6-AP180 was constructed from AP180 clone 36 as described previously (21, 22). A fragment containing the ENTH domain of AP180 was generated from the His6-AP180 plasmid by digestion with SalI, completely removing the segments coding for the carboxyl-terminal parts of AP180. A 647-bp StuI/HindIII fragment of AP180 clone 36 coding for the carboxyl-terminal end of AP180 was cloned between the SmaI and HindIII sites of the pQE30 expression vector (QIAGEN Inc.), resulting in plasmid pQB4, which expresses His6-AP180-(745-896). The remaining 2003-bp StuI/HindIII fragment coding for the amino-terminal and middle parts (segment 328-745) of AP180, as well as the initial cloning vector pBluescript SK+, was again cut with SalI and treated with Klenow fragment to fill up the recessed 3' termini. The resulting 1250-bp fragment was isolated and cloned into the SmaI site of vector pQE31, expressing His6-AP180-(328-745). To obtain a plasmid from which His6-AP180-(328-896) can be expressed, AP180 clone 36 was cut with SalI and HindIII, and the 1907-bp fragment was isolated and cloned between the SalI and HindIII sites of pQE31.

All fusion proteins were purified on an Ni2+-nitrilotriacetic acid-agarose affinity matrix (QIAGEN Inc.) according to the manufacturer's protocol. If not stated otherwise, the bacterial lysates containing the expressed heat-stable His6-epsin 1-(144-575) and His6-AP180-(328-896) fusion proteins were heated in a boiling water bath for 3 min, shock-cooled in blended NaCl and ice water for 5 min, and centrifuged for 15 min at 120,000 × g in a Beckman Ti-70 rotor to remove precipitated heat-denatured proteins. The supernatant was incubated with the affinity matrix. To remove the tag from epsin 1, the fusion protein was digested with 8 units/ml thrombin (ICN, Aurora, OH) for 18 h. Epsin 1 and its fragment were further purified by ion exchange chromatography on MonoQ resin. The protein was eluted at pH 8.0 with a 0-0.5 M NaCl gradient buffered with 0.025 M Tris-HCl. Fractions (1 ml) were collected. AP180 from pig brain was obtained as described previously (15). All proteins used in this study were finally purified by gel filtration through a Superdex 200 HR10/30 column (Amersham Biosciences, Inc.) equilibrated with phosphate-buffered saline (137 mM NaCl, 2.7 mM KCl, 1.9 mM KH2PO4, and 8.2 mM Na2HPO4).

Preparation of Cytosol-- Fresh pig brains were obtained from the local slaughterhouse, immediately stored on ice, and processed within 2 h after slaughter. The brains were homogenized in 250 mM sucrose, 25 mM HEPES, 0.5 mM dithiothreitol, 1 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride (pH 7.3; 1 ml of buffer/g of tissue) using a Potter S homogenizer (B. Braun Biotech International GmbH, Melsungen, Germany) and centrifuged for 70 min at 125,000 × g in a Beckman Ti-45 rotor. The pellet was discarded, and the supernatant was centrifuged for another 70 min as described above. The clarified cytosol was dialyzed against 50 mM Tris and 100 mM NaCl (pH 7.5) overnight. Finally, the cytosol was centrifuged again for 2 h. When not used immediately, the cytosol was shock-frozen in ethanol and dry ice and stored at -80 °C. Frozen cytosol was rapidly thawed in a water bath at 37 °C and then clarified by ultracentrifugation.

Analytical Gel Filtration Chromatography-- Size exclusion chromatography was performed on an Amersham Biosciences fast protein liquid chromatography system with a Superdex 200 HR10/30 column. Elution volumes of purified proteins were determined from the recorder profiles. To determine the elution positions of epsin 1 and AP180 in pig brain cytosol, 500 µl of cytosol were applied to the Superdex column, and 500-µl fractions were collected. Each fraction was analyzed by SDS-PAGE and Western blotting using antibodies against the proteins of interest. The elution volume of each fraction was calculated by adding the dead volume between the photometer of the fast protein liquid chromatography system and the fraction collector to the volume collected up to the middle of the respective fraction. The Western blots were analyzed densitometrically with NIH Image Version 1.62 software, and the relative signal was plotted against the calculated elution volume. The distribution maximum of this curve corresponds to the elution volume of the protein. The Superdex column was calibrated with thyroglobulin (Stokes radius of 8.6 nm) (23), apoferritin (6.6 nm), alcohol dehydrogenase (4.6 nm), bovine serum albumin (3.6 nm), and carbonic anhydrase (2.0 nm) (24). Clathrin cages were used to determine the void volume. Distribution coefficients (KD) were calculated from the elution volume of the standard proteins. Plotting Stokes radii against the square roots of the negative decadic logarithms of the distribution coefficients resulted in a straight line (25). This linear relationship was used to translate elution volumes of epsin 1, AP180, and their derivatives into Stokes radii.

Sucrose Density Gradient Centrifugation-- To estimate the sedimentation coefficients of proteins in cytosol, we used sucrose gradients (5-20%) made up in 0.5 M Tris-HCl (pH 7.0). The gradients were cast in 5-ml thin-walled ultracentrifuge tubes (13 × 51 mm) using a gradient mixer that was connected to a peristaltic pump. The gradients were overlaid with 200 µl of either pig brain cytosol or a mixture of several standard proteins in 0.5 M Tris-HCl (pH 7.0) at a concentration of 0.14 mg/ml each. We used lysozyme (1.91 S), ovalbumin (3.55 S), bovine serum albumin (4.44 S), lactate dehydrogenase (6.93 S), and catalase (11.20 S) as standards (26). The gradients were centrifuged in a Beckman SW 55 Ti rotor at 40,000 rpm for 18 h and fractionated from the meniscus downwards in 220-µl steps using a micropipette. The fractions were analyzed by SDS-PAGE. The standard proteins were visualized with Coomassie Blue, and the proteins of interest were visualized by Western blotting. The linear relationship between the fraction numbers of the distribution maxima of the standard proteins and their sedimentation coefficients was used to determine the s values of cytosolic epsin 1 and AP180. As an internal control, the sedimentation coefficient of G-actin was determined to be 3.2 S, which is very close to the published value (26).

Heat Denaturation-- The susceptibility of epsin 1, AP180, and their fragments to irreversible denaturation was tested by heating them in a boiling water bath for 5 min, followed by shock cooling for 5 min in an NaCl/ice water slurry. 10 µg of the respective protein in 100 µl of phosphate-buffered saline and 1 mg/ml glutathione S-transferase (GST) were subjected to the procedure. Precipitated protein was pelleted by centrifugation for 10 min at 90,000 × g in a Beckman Optima TL ultracentrifuge using a Beckman TLA45 rotor. Supernatant and pellet fractions were analyzed by SDS-PAGE and subsequent Coomassie Blue staining.

Pull-down Experiments and Clathrin Assembly-- Binding experiments with His6-AP180-(328-896) and the immobilized GST-alpha -appendage domain and GST-clathrin terminal domain fusion proteins were performed exactly as described by Scheele et al. (27), as were the clathrin assembly experiments.

Analytical Ultracentrifugation-- Analytical ultracentrifugation was done in a Beckman/Coulter XL-A analytical ultracentrifuge in either eight- or four-place rotors (An-40 or An-60). Sedimentation rate analysis was done with 12-mm path length double sector centerpieces. Sedimentation rate constants were determined by analysis of the boundary movement and were corrected to 20 °C and pure water as solvent (s20,w) (28).

CD Spectroscopy-- CD spectroscopy was performed using a Jobin Yvon Dichrograph III with a bandwidth of 2 nm, a scanning rate of 0.03 nm/s, and a time constant of 2 s. The spectra were evaluated with CDPro software using the expanded reference set of protein spectra as described previously (29).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Molecular Dimensions of Epsin 1 and AP180-- In the course of purifying recombinant epsin 1, we noted that it migrated anomalously slow upon SDS-PAGE, gave rise to sharp but slightly distorted bands, and eluted from gel filtration columns like a much larger protein than predicted by its sequence. Similar observations were made previously with the endocytic accessory protein AP180 (15, 30). To determine whether both proteins share common structural features in addition to the ENTH domain, we embarked on a detailed structural characterization of epsin 1 and AP180 that also included several functional fragments of both proteins (Fig. 1). We started by fractionating pig brain cytosol on a calibrated gel filtration column to separate the proteins according to their hydrodynamic radii. The square root of the negative decadic logarithm of the distribution coefficients (KD) of macromolecules is linearly related to their Stokes radii (25). Using this relationship, we obtained Stokes radii of 5.3 nm for cytosolic epsin 1 and 7.5 nm for AP180 (Fig. 2 and Table I). These values are characteristic for globular proteins with molecular masses of 230 and 550 kDa, respectively; but according to sequence data, epsin 1 has a molecular mass of only ~60 kDa and AP180 of 92 kDa. Assuming that epsin 1 and AP180 are monomers and not associated with any other cytosolic components, these results suggest that epsin 1 and AP180 contain segments that have an extended rod-like structure or that are not compactly folded.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 1.   Domain structures of epsin 1, AP180, and the expressed recombinant fragments and SDS-PAGE of the proteins used in this study. A, schematic view with binding motifs for AP-2 (DP(F/W) and FXDXF) and clathrin indicated. Known protein-protein interactions, including those with the clathrin amino-terminal domain, involve only the central and carboxyl-terminal regions of the proteins. B, purity of the proteins used for biophysical studies as judged by SDS-PAGE. recomb., recombinant.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   Analytical size exclusion chromatography on calibrated gel filtration columns. A, elution profiles of epsin 1 (open circle ) and AP180 () in pig brain cytosol as determined by Western blot analysis of the collected fractions. The elution maxima of the standard proteins are indicated by arrows together with the values for their Stokes radii in nanometers. B and C, plots of the Stokes radii (RS) of standard proteins versus the square roots of the negative decadic logarithms of their distribution coefficients (KD). The respective values calculated from the KD of epsin 1 (B) and AP180 (C) are indicated by arrows.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Hydrodynamic properties of epsin 1, AP180, and their fragments lacking the ENTH domains as determined by different methods
The molecular masses given in the second column were calculated from the compositions based on the amino acid sequences. The last two columns show a comparison of s20,w values in the presence and absence of the chaotropic denaturant guanidinium chloride. The sedimentation coefficients determined by analytical ultracentrifugation have errors of <5%. ND, not determined; RS, Stokes radius.

To exclude the possibility that epsin 1 and AP180 form complexes with other cytosolic components, we determined the Stokes radii of purified recombinant epsin 1 and AP180 by analytical gel filtration. We observed that the values for both proteins are very close to the ones determined for their cytosolic forms (Fig. 2). Because the overall structure of the ENTH domain is already known to be globular (4-6), we focused our analysis on the recombinant fragments His6-epsin 1-(144-625) and His6-AP180-(328-896), which lack the ENTH domain. Both fragments eluted from the gel filtration column only slightly behind the positions of the respective full-length proteins (Fig. 2, B and C). This suggests that the behavior of epsin 1 and AP180 upon gel filtration chromatography is dominated by the structural organization of their carboxyl-terminal segments.

Sedimentation Properties of Epsin 1 and AP180-- To determine whether the observed large Stokes radii of epsin 1 and AP180 might possibly result from self-association, we analyzed the sedimentation properties of epsin 1 and AP180 in 5-20% sucrose gradients. First, the sedimentation velocities of unfractionated cytosolic epsin 1 and AP180 were examined. After ultracentrifugation, the gradient was fractionated, and each fraction was analyzed by SDS-PAGE and Western blotting with antibodies directed against epsin 1 and AP180. A set of standard proteins with known sedimentation coefficients was used to construct a calibration line from which s values of 2.4 for epsin 1 and 2.5 for AP180 were obtained (Fig. 3, A and B; and Table I). Considering the molecular masses of both proteins, these s values are unusually low and suggestive of a very high frictional coefficient. By entering the value for the Stokes radius and that for the s value into the Svedberg equation, it is possible to estimate the molecular mass of a macromolecule. We did this for cytosolic AP180 and epsin 1 and arrived at molecular masses of 90 and 60 kDa, respectively. These values suggest that both proteins exist in cytosol mainly as monomers.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   Sucrose gradient centrifugation of pig brain cytosol. After centrifugation of pig brain cytosol through a 5-20% sucrose gradient, 23 fractions were collected and analyzed by Western blotting. A, distribution of epsin 1 (open circle ) and AP180 () in the gradient. Distribution maxima of standard proteins are indicated by arrows; their sedimentation coefficients are given in Svedberg units. B, plot of the sedimentation coefficients of the standard proteins versus the fraction numbers of their distribution maxima. The peak positions of epsin 1 and AP180 are indicated by arrows.

We next used sedimentation-diffusion equilibrium ultracentrifugation to directly determine the molecular masses of highly purified recombinant epsin 1, AP180, and their fragments lacking the ENTH domains. The data indicate that all examined proteins are predominantly monomers (data not shown). We also analyzed the sedimentation properties of His6-epsin 1-(144-625) and His6-AP180-(328-896) in strong chaotropic protein denaturants (3-6 M guanidinium chloride) and observed only very small changes in their frictional coefficients upon denaturation (Table I). The observed hydrodynamic size is consistent with either an extended rod with a thickness of 1.5-2.0 nm and a length of some 50 nm or, alternatively, a poorly folded polypeptide chain. Taken together, our data obtained from quantitative gel filtration chromatography and ultracentrifugation strongly suggest that the carboxyl-terminal parts of epsin 1 and AP180 are rather extended, with the consequence that they behave like very large proteins on gel filtration columns and like molecular parachutes during ultracentrifugation.

CD Spectroscopy Reveals Unstructured Polypeptide Chains-- Whereas hydrodynamic methods are suitable for determining the molecular dimensions of macromolecules, they do not, however, tell us whether the molecule is an extended structure such as a rod (e.g. a coiled coil) or an unstructured random coil. To distinguish between these two possibilities, recombinant epsin 1, AP180, and several of their recombinantly expressed fragments were analyzed by CD spectroscopy. The spectra of epsin 1 and AP180 are very similar. Both show typical characteristics of a moderate alpha -helical content, but are obviously dominated by the signature of random coils. Evaluation of the raw data with CDPro software indicated an alpha -helical content of 21% for epsin 1 and of 22% for AP180 (Table II). In the spectra of the fragments lacking the ENTH domains (His6-epsin 1-(144-575) and His6-AP180-(328-896)), the alpha -helical characteristics were almost completely lost, whereas the content of random structures increased from 56 to 66% for the epsin 1 fragment and from 55 to 84% for the AP180 fragment (Fig. 4, A and B). In contrast, in the His6-AP180-(1-329) fragment, which includes the ENTH domain, the alpha -helical content reached 42%, accounting approximately for the total alpha -helical content of intact AP180. We also divided the carboxyl-terminal AP180 segment into two fragments and obtained their CD spectra. The first fragment extended from Val328 to Gly745, and the second from Gly745 to Leu896. As expected, the spectra of both fragments revealed little secondary structure; but more important, the sum of the molar ellipticities in the spectra of the three recombinant AP180 fragments (His6-AP180-(1-329), -(328-745), and -(745-896)) was identical to that in the spectrum of recombinant full-length AP180 and similar to that in the spectrum of AP180 isolated from pig brain (Fig. 4D). This observation ruled out the possibility that the lack of secondary structure was an artifact caused by expressing only short fragments that cannot fold properly due to the disruption of intramolecular interactions. The small discrepancies in the beta -structure content between recombinant and pig brain AP180 are most likely explained by contaminating proteins present in the AP180 preparation.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Secondary structure contents of recombinant epsin 1, pig brain AP180, recombinant AP180, and recombinantly expressed fragments of both proteins
CD spectra were evaluated with CDPro software as described under "Experimental Procedures." Notably, the ENTH domains of both proteins account for almost all the alpha -helical content of epsin 1 and AP180, whereas the carboxyl-terminal parts have an extremely high content of random structures. CCV, clathrin-coated vesicles.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Secondary structures of epsin 1 and AP180. A and B, comparison of the CD spectra of full-length AP180 and epsin 1 and their fragments, respectively. The spectra of AP180 are characteristic for proteins with modest alpha -helical content. In contrast, the spectrum of the ENTH domain of AP180 is dominated by its alpha -helical content, whereas the spectra of the recombinant carboxyl-terminal portions from both proteins do not match the signatures of known conventional secondary structures. C, comparison of the spectra of recombinant His6-AP180 and AP180 isolated from pig brain clathrin-coated vesicles (CCV). Both spectra are almost identical, suggesting that the unusual CD spectrum is a characteristic not only of the recombinant protein. D, comparison of averaged spectra of full-length AP180 and the sum of the spectra of its recombinant fragments. Both spectra are almost identical, so the observed loss of secondary structure when measuring the carboxyl-terminal parts is not due to disruption of intramolecular interactions. deg, degrees.

Taken together, these results show that besides their respective ENTH domains, epsin 1 and AP180 contain no conventional secondary structure, but are overall unstructured, randomly coiled, and therefore hydrodynamically large polypeptide chains. However, we cannot entirely rule out the possibility that short segments of the polypeptide chains engage in intramolecular interactions, but they seem to lack overall secondary structure and hence also tertiary structure.

Epsin 1 and AP180 without the ENTH Domains Are Heat-stable-- The irreversible denaturation of most proteins upon heating is due to the disruption of native secondary and tertiary structures and concomitant transient exposure of hydrophobic segments. These lead to coagulation of the denatured protein either during heating or upon rapid cooling when the polypeptide chain follows a wrong refolding pathway and becomes trapped in non-native conformations. Therefore, we assumed that where there is no structure, the fragments that lack the ENTH domains ought to remain soluble upon heating in a boiling water bath. To test this hypothesis, we heat-denatured both the amino-terminally truncated fragments of epsin 1 and AP180 and the recombinant full-length proteins, shock-cooled them, and then pelleted any coagulated protein by centrifugation. SDS-PAGE analysis of the supernatant and pellet fractions indeed demonstrated that His6-epsin 1-(144-625) and His6-AP180-(328-896) were both heat-stable, whereas the full-length proteins and GST added as a carrier and internal standard did almost quantitatively precipitate (Fig. 5A). We next tested whether boiling of the recombinant AP180 fragment His6-AP180-(328-896) would compromise its functions. AP180-(328-896) is known to bind the clathrin amino-terminal domain, to associate with the alpha -appendage domain of the AP-2 adaptor complex, and to induce assembly of clathrin triskelia (11, 31). Binding of the boiled protein fragments to clathrin and the adaptor was assessed by pull-down experiments using the immobilized recombinant alpha -appendage domain and the clathrin amino-terminal domain as baits. No significant differences between the untreated and heat-treated His6-AP180-(328-896) fragments were observed (Fig. 5B). Similarly, heating did not affect the ability of the fragment to induce clathrin assembly (Fig. 5C).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 5.   Carboxyl-terminal segments of epsin 1 and AP180 are heat-stable. A, recombinant epsin 1 and AP180 as well as their fragments lacking the ENTH domains were boiled in the presence of GST and shock-cooled. Denatured precipitated proteins were pelleted by centrifugation. Whereas the full-length proteins were almost completely in the pellet (p), the heat-stable carboxyl-terminal fragments remained in the supernatant (s). B, pull-down experiments were carried out with the immobilized GST-alpha -appendage domain (GST-alpha app.) of the AP-2 adaptor (1.8 µmol) and the GST-amino-terminal domain (GST-TD) of the clathrin heavy chain (HC) (1.1 µmol). Immobilized GST beads (1.8 µmol) served as a control. The beads were incubated with untreated or boiled 6x-His-AP180-(328-896) in buffer G (25 mM Hepes, 125 mM potassium acetate, 5 mM magnesium acetate, pH 7.1) for 30 min. The concentration of the recombinant fragment was 0.73 µM. The beads were washed and recovered by low speed centrifugation and then analyzed by SDS-PAGE and immunoblotting. Equal amounts of supernatant and pellet fractions were loaded onto the gel. C, assembly experiments were carried out with heat-treated 6x-His-AP180-(328-896). Clathrin (1.4 × 10-10 mol) was incubated on ice in buffer G for 1 h in a final volume of 100 µl with 1.5 × 10-10 mol of either untreated or boiled 6x-His-AP180-(328-896). Assembled clathrin was separated from free triskelia by ultracentrifugation. Aliquots of the supernatant and resuspended pellets were subjected to SDS-PAGE. Proteins were stained with Coomassie Blue. Note that boiling did not significantly affect the assembly-promoting activity of 6x-His-AP180-(328-896). LC, light chain.

Epsin Promotes Clathrin Assembly-- Given that epsin 1 and AP180 not only share homology in the ENTH domain, but have an overall similar structural organization, we wondered whether they might have more in common than so far assumed. The best characterized functional feature of AP180 is its ability to promote the assembly of clathrin cages from free triskelia under physiological conditions in vitro. Therefore, we also tested epsin 1 for possible clathrin assembly activity and found that it is indeed capable of supporting clathrin association with cages (Fig. 6). In fact, it is at least as efficient as His6-AP180-(328-896). Assuming that, in epsin 1, this activity is also located in the carboxyl-terminal part of the protein, we tested fragment His6-epsin 1-(144-575). As expected, this epsin 1 fragment also possessed assembly activity, although it was somewhat lower compared with that of the full-length protein. Electron micrographs showed that the cages were slightly larger and less homogeneous than those assembled by AP180 or His6-AP180-(328-896) (Fig. 6).


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 6.   Epsin 1 promotes clathrin assembly. Free clathrin triskelia were incubated with recombinant full-length epsin 1, a recombinantly expressed fragment of epsin 1 lacking the ENTH domain, and 6x-His-AP180-(328-896) as a positive control. As a negative control, clathrin was incubated without any additions. A, Coomassie Blue staining/SDS-PAGE of the supernatants (s) and pellets (p) after ultracentrifugation of the reaction mixtures showed that full-length epsin 1 very efficiently assembled clathrin. His6-epsin 1-(144-575) also assembled clathrin, albeit less efficiently than the full-length protein. B-D, shown are electron micrographs of negatively stained clathrin cages assembled by epsin 1 (B) and its fragment (C). The cages appear slightly larger and less homogeneous than those formed by AP180 (D).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Clathrin triskelia and the AP-2 adaptor complex are the principal components of the endocytic machinery. They are supported by accessory proteins that function as structural or regulatory factors at various stages in the biogenesis of plasma membrane-derived clathrin-coated vesicles. Here, we have focused on the accessory proteins AP180 and epsin 1. Both proteins bind to PI-4,5-P2-containing membranes through their respective ENTH domains and to clathrin and AP-2 through short peptide motifs in their carboxyl-terminal segments. Besides the ENTH domain and DP(F/W) peptide motifs, epsin 1 and AP180 share little sequence homology. However, we have shown here that both proteins are monomers with long poorly structured carboxyl-terminal segments that behave like flexible polymers. This manifests itself in unusually large hydrodynamic radii, correspondingly low sedimentation coefficients, and resistance to irreversible heat denaturation. In epsin 1, the peptide motifs involved in binding the clathrin amino-terminal domain are the type II clathrin box motif 257LMDLADV and the type I motif 480LVDLD (14). It has been suggested that the two chemically distinct motifs recognize different surfaces on the clathrin amino-terminal domain (14). Assuming a fully extended polypeptide chain, the motifs could be as far as 155 nm apart, which corresponds roughly to the circumference of a small clathrin-coated vesicle. The average or effective distance between the clathrin box motifs will probably be considerable shorter than 155 nm, but certainly very much longer than required for an interaction between different surfaces on the same globular clathrin amino-terminal domain, which has a diameter of only ~5 nm (32). This suggests that epsin 1 is designed to engage simultaneously two clathrin amino-terminal domains rather than one. Our observation that epsin 1 can function as an assembly protein supports this conjecture. In between the two clathrin-binding motifs, there are eight copies of the tripeptide DPW, which was shown previously to bind the alpha -appendage domain of the AP-2 adaptor (12). Their maximal spacing averages 10 ± 2 nm, and they could therefore associate simultaneously with several AP-2 complexes.

AP180 is the most effective clathrin assembly protein (33), and it also associates with the alpha -appendage domain of the AP-2 adaptor (34, 35). Its flexible carboxyl-terminal segment Val328-Leu896 contains no typical clathrin box motif, but does have five DLL repeats that have been related to the assembly function of AP180 (11). In addition, AP180 contains two DPF peptide motifs, which were shown to be involved in AP-2 binding in amphiphysin, auxilin-1 and -2, and Eps15. Moreover, AP180 contains three FXDXF motifs that were recently demonstrated to mediate binding of the accessory protein HIP1 to AP-2 (19). One of them (640FGDAF) occurs within AP180-(623-680), which binds AP-2 and competes with intact AP180 for AP-2 binding (31).

Several lines of evidences suggest that the interactions between short peptide motifs and their usually stably folded binding partners are of low affinity. For example, despite the apparent high affinity of AP180 for clathrin cages, it proved initially difficult to directly identify the clathrin amino-terminal domain as its contact surface on the heavy chain (36). Only after using recombinantly expressed GST-clathrin amino-terminal domain fusion proteins immobilized at high density on glutathione-Sepharose beads was it possible to prove an interaction between AP180 and the amino-terminal domain (11). This suggests that multimerization of binding sites is required for stable interactions. These might occur either by immobilizing monovalent binding partners on beads or membranes or by their polymerization into supramolecular structures such as a clathrin cage. Accordingly, in most endocytic accessory proteins, short peptide motifs occur in multiple copies. The cooperativity of the interactions provides not only stability, but also specificity. In this scenario, specificity is not born out of a tight key and lock-type fit, but results from many loosely fitting contacts between the interaction partners. Flexibility of the residual structure allows for a random search for additional binding partners without a biased orientation. Recruitment of additional proteins to the ones already present would transform fleeting assemblies into stable structures. This process would be akin to a condensation reaction that consists of a nucleation phase followed by an elongation phase, which, when applied to a clathrin-coated pit, would correspond to the growth of the clathrin lattice. However, the resulting structure could be described as dynamically stable. Upon interfering with individual weak interactions, e.g. by protein phosphorylation at or near the interaction sites or by offering alternative binding partners, the lattice could undergo rapid local and eventually global changes. Thus, by combining multiple weak interactions in a cooperative manner, a dynamic macromolecular structure can be constructed that can also rapidly be remodeled.

Which role do epsin 1 and AP180 play in coat assembly on the plasma membrane? There is already ample evidence that clathrin coat formation on the plasma membrane is linked to lipid metabolism. Current models suggest that locally high concentrations of PI-4,5-P2 might attract epsin 1, AP180, and AP-2 to select plasma membrane domains (8). With their long flexible polypeptide chains, AP180 and epsin 1 might be more suited to ensnare soluble and membrane-bound coat components than other more structured lipid-binding proteins such as HIP1/HIP1R and the amphiphysins. The affinity of AP-2 for epsin 1 and AP180 might then lead to AP-2 binding and thereby stabilization of a membrane subdomain. Subsequent recruitment of multivalent clathrin triskelia and their polymerization into a lattice will not only fortify the coat, but also extend the coated area (Fig. 7). The efficient cooperation between AP-2 and AP180 in the recruitment of clathrin triskelia to lipid monolayers was recently demonstrated in vitro (7).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 7.   Schematic illustrating early events in the assembly of the endocytic machinery at the plasma membrane. Clathrin coat formation is probably initiated by locally high concentrations of the lipid PI-4,5-P2 that might attract epsin 1, AP180/CALM (depicted in yellow and red), and AP-2 (shown in blue) to select plasma membrane domains (8). The long and flexible segments of AP180 and epsin 1 may be primarily designed to concentrate adaptors and clathrin from the cytosol to this domain. The cooperativity of the interactions of clathrin triskelia with membrane-bound components and with each other provides the driving force for rapid coat formation (see "Discussion" for details).

Why then are two distinct proteins (epsin 1 and AP180) with similar functions needed? First, our pull-down experiments using the immobilized alpha -appendage domain and the clathrin amino-terminal domain as baits suggested that epsin 1 binds with somewhat higher affinity to the alpha -appendage domain compared with AP180 (data not shown), whereas AP180 proved to be slightly more promiscuous with respect to lipid binding (6, 7). Moreover, both proteins support assembly of clathrin, but only AP180 is also capable of precisely controlling the size of the resulting coat (15, 16). Also, epsin 1 contains the peptide motif NPF, which binds to Eps15 homology domains like that of the accessory protein Eps15, whereas AP180 lacks this capacity, as does its non-neuronal homolog CALM (37). Taken together, this suggests a division of labor between epsin 1 and AP180 in recruiting additional coat components.

Almost all of the known endocytic accessory proteins interact with the clathrin amino-terminal domain and with the alpha -appendage domain of AP-2. Immunofluorescence studies of fixed cells suggest their collective presence in each of the clathrin-positive fluorescent dots. Because these proteins cannot possibly all be present in stoichiometric amounts at the same time, it is likely that they might act not only at different places in a growing lattice, but possibly also sequentially, as would be expected for a vectorial process. Determining the order of the protein-protein interactions that keep the endocytic machine running will constitute a major challenge for the future.

    ACKNOWLEDGEMENTS

We than H. Ungewickell and C. Lemke for expert technical assistance.

    FOOTNOTES

* This work was supported by the German Research Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Cell Biology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30125 Hannover, Germany. Tel.: 49-511-532-6744; Fax: 49-511-532-3903; E-mail: ungewickell.ernst@mh-hannover.de.

Published, JBC Papers in Press, December 26, 2001, DOI 10.1074/jbc.M111587200

    ABBREVIATIONS

The abbreviations used are: ENTH, epsin N-terminal homology; PI-4, 5-P2, phosphatidylinositol 4,5-bisphosphate; GST, glutathione S-transferase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Kirchhausen, T. (2000) Annu. Rev. Biochem. 69, 699-727[CrossRef][Medline] [Order article via Infotrieve]
2. McMahon, H. T. (1999) Curr. Biol. 9, R332-R335[CrossRef][Medline] [Order article via Infotrieve]
3. Chen, H., Fre, S., Slepnev, V. I., Capua, M. R., Takei, K., Butler, M. H., Di, Fiore, P. P., and De Camilli, P. (1998) Nature 394, 793-797[CrossRef][Medline] [Order article via Infotrieve]
4. Mao, Y., Chen, J., Maynard, J. A., Zhang, B., and Quiocho, F. A. (2001) Cell 104, 433-440[CrossRef][Medline] [Order article via Infotrieve]
5. Hyman, J., Chen, H., Di, Fiore, P. P., De, Camilli, P., and Brunger, A. T. (2000) J. Cell Biol. 149, 537-546[Abstract/Free Full Text]
6. Itoh, T., Koshiba, S., Kigawa, T., Kikuchi, A., Yokoyama, S., and Takenawa, T. (2001) Science 291, 1047-1051[Abstract/Free Full Text]
7. Ford, M. G., Pearse, B. M., Higgins, M. K., Vallis, Y., Owen, D. J., Gibson, A., Hopkins, C. R., Evans, P. R., and McMahon, H. T. (2001) Science 291, 1051-1055[Abstract/Free Full Text]
8. Takei, K., and Haucke, V. (2001) Trends Cell Biol. 11, 385-391[CrossRef][Medline] [Order article via Infotrieve]
9. Owen, D. J., Vallis, Y., Noble, M. E., Hunter, J. B., Dafforn, T. R., Evans, P. R., and McMahon, H. T. (1999) Cell 97, 805-815[CrossRef][Medline] [Order article via Infotrieve]
10. Owen, D. J., Vallis, Y., Pearse, B. M., McMahon, H. T., and Evans, P. R. (2000) EMBO J. 19, 4216-4227[CrossRef][Medline] [Order article via Infotrieve]
11. Morgan, J. R., Prasad, K., Hao, W., Augustine, G. J., and Lafer, E. M. (2000) J. Neurosci. 20, 8667-8676[Abstract/Free Full Text]
12. Rosenthal, J. A., Chen, H., Slepnev, V. I., Pellegrini, L., Salcini, A. E., Di, Fiore, P. P., and De Camilli, P. (1999) J. Biol. Chem. 274, 33959-33965[Abstract/Free Full Text]
13. Drake, M. T., Downs, M. A., and Traub, L. M. (2000) J. Biol. Chem. 275, 6479-6489[Abstract/Free Full Text]
14. Drake, M. T., and Traub, L. M. (2001) J. Biol. Chem. 276, 28700-28709[Abstract/Free Full Text]
15. Ahle, S., and Ungewickell, E. (1986) EMBO J. 5, 3143-3149[Medline] [Order article via Infotrieve]
16. Ye, W., and Lafer, E. M. (1995) J. Neurosci. Res. 41, 15-26[CrossRef][Medline] [Order article via Infotrieve]
17. Zhang, B., Koh, Y. H., Beckstead, R. B., Budnik, V., Ganetzky, B., and Bellen, H. J. (1998) Neuron 21, 1465-1475[CrossRef][Medline] [Order article via Infotrieve]
18. Salcini, A. E., Confalonieri, S., Doria, M., Santolini, E., Tassi, E., Minenkova, O., Cesareni, G., Pelicci, P. G., and Di Fiore, P. P. (1997) Genes Dev. 11, 2239-2249[Abstract/Free Full Text]
19. Mishra, S. K., Agostinelli, N. R., Brett, T. J., Mizukami, I., Ross, T. S., and Traub, L. M. (2001) J. Biol. Chem. 276, 46230-46236[Abstract/Free Full Text]
20. Prasad, K., and Lippoldt, R. E. (1988) Biochemistry 27, 6098-6104[CrossRef][Medline] [Order article via Infotrieve]
21. Morris, S. A., Schroder, S., Plessmann, U., Weber, K., and Ungewickell, E. (1993) EMBO J. 12, 667-675[Medline] [Order article via Infotrieve]
22. Norris, F. A., Ungewickell, E., and Majerus, P. W. (1995) J. Biol. Chem. 270, 214-217[Abstract/Free Full Text]
23. Le Maire, M., Aggerbeck, L. P., Monteilhet, C., Andersen, J. P., and Moller, J. V. (1986) Anal. Biochem. 154, 525-535[CrossRef][Medline] [Order article via Infotrieve]
24. Potschka, M. (1987) Anal. Biochem. 162, 47-64[CrossRef][Medline] [Order article via Infotrieve]
25. Laurent, T. C., and Killander, J. (1964) J. Chromatogr. 14, 331-339[CrossRef]
26. Sober, H. A. (1970) CRC Handbook of Biochemistry: Selected Data for Molecular Biology , 2nd Ed. , pp. C-10-C-25, Chemical Rubber Co., Cleveland, OH
27. Scheele, U., Kalthoff, C., and Ungewickell, E. (2001) J. Biol. Chem. 276, 36131-36138[Abstract/Free Full Text]
28. Laue, T. M., Shah, B. D., Ridgeway, T. M., and Pelletier, S. L. (1992) in Computer-aided Interpretation of Analytical Sedimentation Data for Proteins (Harding, S. E. , Rowe, A. J. , and Horton, J. C., eds) , pp. 90-125, Royal Society of Chemistry, Cambridge, United Kingdom
29. Sreerama, N., and Woody, R. W. (2000) Anal. Biochem. 287, 252-260[CrossRef][Medline] [Order article via Infotrieve]
30. Murphy, J. E., Pleasure, I. T., Puszkin, S., Prasad, K., and Keen, J. H. (1991) J. Biol. Chem. 266, 4401-4408[Abstract/Free Full Text]
31. Hao, W., Luo, Z., Zheng, L., Prasad, K., and Lafer, E. M. (1999) J. Biol. Chem. 274, 22785-22794[Abstract/Free Full Text]
32. ter Haar, E., Musacchio, A., Harrison, S. C., and Kirchhausen, T. (1998) Cell 95, 563-573[CrossRef][Medline] [Order article via Infotrieve]
33. Lindner, R., and Ungewickell, E. (1992) J. Biol. Chem. 267, 16567-16573[Abstract/Free Full Text]
34. Kohtz, D. S., and Puszkin, S. (1988) J. Biol. Chem. 263, 7418-7425[Abstract/Free Full Text]
35. Wang, L. H., Sudhof, T. C., and Anderson, R. G. (1995) J. Biol. Chem. 270, 10079-10083[Abstract/Free Full Text]
36. Murphy, J. E., and Keen, J. H. (1992) J. Biol. Chem. 267, 10850-10855[Abstract/Free Full Text]
37. Tebar, F., Bohlander, S. K., and Sorkin, A. (1999) Mol. Biol. Cell 10, 2687-2702[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. R. Thieman, S. K. Mishra, K. Ling, B. Doray, R. A. Anderson, and L. M. Traub
Clathrin Regulates the Association of PIPKI{gamma}661 with the AP-2 Adaptor {beta}2 Appendage
J. Biol. Chem., May 15, 2009; 284(20): 13924 - 13939.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
P. A. Keyel, J. R. Thieman, R. Roth, E. Erkan, E. T. Everett, S. C. Watkins, J. E. Heuser, and L. M. Traub
The AP-2 Adaptor {beta}2 Appendage Scaffolds Alternate Cargo Endocytosis
Mol. Biol. Cell, December 1, 2008; 19(12): 5309 - 5326.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. J. Brady, Y. Wen, and T. J. O'Halloran
The ENTH and C-terminal domains of Dictyostelium epsin cooperate to regulate the dynamic interaction with clathrin-coated pits
J. Cell Sci., October 15, 2008; 121(20): 3433 - 3444.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
L. Maldonado-Baez, M. R. Dores, E. M. Perkins, T. G. Drivas, L. Hicke, and B. Wendland
Interaction between Epsin/Yap180 Adaptors and the Scaffolds Ede1/Pan1 Is Required for Endocytosis
Mol. Biol. Cell, July 1, 2008; 19(7): 2936 - 2948.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-H. Huang, Z. Qi, F. Wu, L. Kotula, S. Jiang, and Y.-H. Chen
Interaction of HIV-1 gp41 Core with NPF Motif in Epsin: IMPLICATION IN ENDOCYTOSIS OF HIV
J. Biol. Chem., May 30, 2008; 283(22): 14994 - 15002.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. K. Mishra, A. Jha, A. L. Steinhauser, V. A. Kokoza, C. H. Washabaugh, A. S. Raikhel, W. A. Foster, and L. M. Traub
Internalization of LDL-receptor superfamily yolk-protein receptors during mosquito oogenesis involves transcriptional regulation of PTB-domain adaptors
J. Cell Sci., April 15, 2008; 121(8): 1264 - 1274.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. E. Olesen, M. G. J. Ford, E. M. Schmid, Y. Vallis, M. M. Babu, P. H. Li, I. G. Mills, H. T. McMahon, and G. J. K. Praefcke
Solitary and Repetitive Binding Motifs for the AP2 Complex {alpha}-Appendage in Amphiphysin and Other Accessory Proteins
J. Biol. Chem., February 22, 2008; 283(8): 5099 - 5109.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Poupon, M. Girard, V. Legendre-Guillemin, S. Thomas, L. Bourbonniere, J. Philie, N. A. Bright, and P. S. McPherson
Clathrin light chains function in mannose phosphate receptor trafficking via regulation of actin assembly
PNAS, January 8, 2008; 105(1): 168 - 173.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. D. Allaire, B. Ritter, S. Thomas, J. L. Burman, A. Yu. Denisov, V. Legendre-Guillemin, S. Q. Harper, B. L. Davidson, K. Gehring, and P. S. McPherson
Connecdenn, A Novel DENN Domain-Containing Protein of Neuronal Clathrin-Coated Vesicles Functioning in Synaptic Vesicle Endocytosis
J. Neurosci., December 20, 2006; 26(51): 13202 - 13212.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
G. Costaguta, M. C. Duncan, G. E. Fernandez, G. H. Huang, and G. S. Payne
Distinct Roles for TGN/Endosome Epsin-like Adaptors Ent3p and Ent5p
Mol. Biol. Cell, September 1, 2006; 17(9): 3907 - 3920.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Hinrichsen, A. Meyerholz, S. Groos, and E. J. Ungewickell
Bending a membrane: How clathrin affects budding
PNAS, June 6, 2006; 103(23): 8715 - 8720.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Legendre-Guillemin, M. Metzler, J.-F. Lemaire, J. Philie, L. Gan, M. R. Hayden, and P. S. McPherson
Huntingtin Interacting Protein 1 (HIP1) Regulates Clathrin Assembly through Direct Binding to the Regulatory Region of the Clathrin Light Chain
J. Biol. Chem., February 18, 2005; 280(7): 6101 - 6108.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. G. Roth
Phosphoinositides in Constitutive Membrane Traffic
Physiol Rev, July 1, 2004; 84(3): 699 - 730.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Barth and S. E. H. Holstein
Identification and functional characterization of Arabidopsis AP180, a binding partner of plant {alpha}C-adaptin
J. Cell Sci., April 15, 2004; 117(10): 2051 - 2062.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Jha, N. R. Agostinelli, S. K. Mishra, P. A. Keyel, M. J. Hawryluk, and L. M. Traub
A Novel AP-2 Adaptor Interaction Motif Initially Identified in the Long-splice Isoform of Synaptojanin 1, SJ170
J. Biol. Chem., January 16, 2004; 279(3): 2281 - 2290.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
V. Legendre-Guillemin, S. Wasiak, N. K. Hussain, A. Angers, and P. S. McPherson
ENTH/ANTH proteins and clathrin-mediated membrane budding
J. Cell Sci., January 1, 2004; 117(1): 9 - 18.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. K. Soutar, R. P. Naoumova, and L. M. Traub
Genetics, Clinical Phenotype, and Molecular Cell Biology of Autosomal Recessive Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 1963 - 1970.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. Morgan, K. Prasad, S. Jin, G. J. Augustine, and E. M. Lafer
Eps15 Homology Domain-NPF Motif Interactions Regulate Clathrin Coat Assembly during Synaptic Vesicle Recycling
J. Biol. Chem., August 29, 2003; 278(35): 33583 - 33592.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. L. Klebig, M. D. Wall, M. D. Potter, E. L. Rowe, D. A. Carpenter, and E. M. Rinchik
Mutations in the clathrin-assembly gene Picalm are responsible for the hematopoietic and iron metabolism abnormalities in fit1 mice
PNAS, July 8, 2003; 100(14): 8360 - 8365.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Scheele, J. Alves, R. Frank, M. Duwel, C. Kalthoff, and E. Ungewickell
Molecular and Functional Characterization of Clathrin- and AP-2-binding Determinants within a Disordered Domain of Auxilin
J. Biol. Chem., July 3, 2003; 278(28): 25357 - 25368.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. C. Aguilar, H. A. Watson, and B. Wendland
The Yeast Epsin Ent1 Is Recruited to Membranes through Multiple Independent Interactions
J. Biol. Chem., March 14, 2003; 278(12): 10737 - 10743.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. Hirst, A. Motley, K. Harasaki, S. Y. Peak Chew, and M. S. Robinson
EpsinR: an ENTH Domain-containing Protein that Interacts with AP-1
Mol. Biol. Cell, February 1, 2003; 14(2): 625 - 641.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
I. G. Mills, G. J.K. Praefcke, Y. Vallis, B. J. Peter, L. E. Olesen, J. L. Gallop, P. J. G. Butler, P. R. Evans, and H. T. McMahon
EpsinR: an AP1/clathrin interacting protein involved in vesicle trafficking
J. Cell Biol., January 21, 2003; 160(2): 213 - 222.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. K. Mishra, S. C. Watkins, and L. M. Traub
The autosomal recessive hypercholesterolemia (ARH) protein interfaces directly with the clathrin-coat machinery
PNAS, December 10, 2002; 99(25): 16099 - 16104.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
C. Kalthoff, S. Groos, R. Kohl, S. Mahrhold, and E. J. Ungewickell
Clint: A Novel Clathrin-binding ENTH-Domain Protein at the Golgi
Mol. Biol. Cell, November 1, 2002; 13(11): 4060 - 4073.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. Wasiak, V. Legendre-Guillemin, R. Puertollano, F. Blondeau, M. Girard, E. de Heuvel, D. Boismenu, A. W. Bell, J. S. Bonifacino, and P. S. McPherson
Enthoprotin: a novel clathrin-associated protein identified through subcellular proteomics
J. Cell Biol., September 3, 2002; 158(5): 855 - 862.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/10/8209    most recent
M111587200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kalthoff, C.
Right arrow Articles by Ungewickell, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalthoff, C.
Right arrow Articles by Ungewickell, E. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement